Cargando…

Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis

BACKGROUND: To investigate the prognostic value of magnetic resonance imaging (MRI) findings in the prognosis of patients with leptomeningeal metastasis from lung adenocarcinoma. METHODS: Patients with lung adenocarcinoma complicated with cytologically confirmed leptomeningeal metastasis who visited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xiaoxing, Pan, Ruili, Chen, Minjiang, Zhao, Jing, Zhong, Wei, Wang, Hanping, Si, Xiaoyan, Zhang, Xiaotong, Zhang, Li, Xu, Yan, Wang, Mengzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977178/ https://www.ncbi.nlm.nih.gov/pubmed/35238486 http://dx.doi.org/10.1111/1759-7714.14362

Ejemplares similares

Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases
por: Ye, Qiuyue, et al.
Publicado: (2023)

Factors Linked to Prognosis in Patients with Leptomeningeal Metastasis Diagnosed by Spinal Magnetic Resonance Imaging
por: Kamoda, Hiroto, et al.
Publicado: (2019)

Unusual magnetic resonance imaging findings of brain and leptomeningeal metastasis in lung adenocarcinoma: A case report
por: Li, Na, et al.
Publicado: (2022)

A Rare Case of Metastasis of Gastric Adenocarcinoma to the Leptomeninges
por: Doshi, Krishna, et al.
Publicado: (2023)

Ovarian Adenocarcinoma With Leptomeningeal Metastases
por: Bayas, Angel, et al.
Publicado: (2022)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

Systematic Immunological Level Determined the Prognosis of Leptomeningeal Metastasis in Lung Cancer
por: Hong, Ye, et al.
Publicado: (2022)

Hemidystonia as an Initial Manifestation of Leptomeningeal Metastasis
por: Jung, Hyun-Jung, et al.
Publicado: (2009)

A case report of prostate adenocarcinoma with leptomeningeal carcinomatosis and intracerebral metastasis
por: Fazilat‐Panah, Danial, et al.
Publicado: (2021)

Diagnostic Reliability of Leptomeningeal Disease Using Magnetic Resonance Imaging
por: Harris, Philippe, et al.
Publicado: (2019)

Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
por: Niwińska, Anna, et al.
Publicado: (2013)

Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
por: Bönig, Lena, et al.
Publicado: (2019)

Leptomeningeal Metastasis in Gliomas : Clinical Characteristics and Risk Factors
por: Yang, Jeyul, et al.
Publicado: (2023)

Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis
por: Nie, Naifu, et al.
Publicado: (2022)

A case report of endometrial adenocarcinoma with leptomeningeal metastases
por: Fazilat‐Panah, Danial, et al.
Publicado: (2021)

Abivertinib in patients with T790M‐positive advanced NSCLC and its subsequent treatment with osimertinib
por: Wang, Hanping, et al.
Publicado: (2020)

Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis
por: Yoo, Byong Chul, et al.
Publicado: (2017)

Identification of Cerebrospinal Fluid MicroRNAs Associated With Leptomeningeal Metastasis From Lung Adenocarcinoma
por: Pan, Zhenyu, et al.
Publicado: (2020)

Primary leptomeningeal oligodendrogliomatosis
por: Mathews, Marlon S., et al.
Publicado: (2009)

Leptomeningeal involvement in CLL
por: Chantepie, Sylvain P., et al.
Publicado: (2014)

Tuberculous Leptomeningitis Basilar
por: Giuseppe, Gerosa
Publicado: (1897)

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China
por: Miao, Kang, et al.
Publicado: (2022)

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
por: Miao, Kang, et al.
Publicado: (2022)

Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non– small cell lung cancer
por: Miao, Kang, et al.
Publicado: (2022)

Leptomeningeal metastasis in breast cancer – a systematic review
por: Scott, Brian J., et al.
Publicado: (2015)

A case report of prostate cancer with leptomeningeal metastasis
por: Dehghani, Mansoureh, et al.
Publicado: (2021)

Hemangioblastoma with late leptomeningeal metastasis: a case report
por: Poiset, Spencer J., et al.
Publicado: (2023)

BSLD-05 ESTABLISHMENT AND CHARACTERIZATION OF MOUSE MODELS OF LEPTOMENINGEAL METASTASIS
por: Derderian, Camille, et al.
Publicado: (2023)

Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
por: Zhong, Shuai, et al.
Publicado: (2023)

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

BSLD-06 UNVEILING THE RE-PROGRAMMING OF CHOROID PLEXUS AND LEPTOMENINGEAL METASTASIS
por: Nobre, Ana Rita, et al.
Publicado: (2023)

Glioblastoma Multiforme in the Pineal Region with Leptomeningeal Dissemination and Lumbar Metastasis
por: Matsuda, Ryosuke, et al.
Publicado: (2015)

41. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS
por: Le Rhun, Emilie, et al.
Publicado: (2020)

Durable clinical benefit of letrozole in leptomeningeal metastasis of breast cancer
por: Takanashi, Toshihiro, et al.
Publicado: (2019)

Leptomeningeal Metastasis from Adrenocortical Carcinoma: A Case Report
por: Schreiber, Anna R, et al.
Publicado: (2020)

Leptomeningeal Carcinomatosis With Optic Nerve Metastasis Secondary to Breast Cancer
por: Chew, Chiachee, et al.
Publicado: (2021)

Leptomeningeal metastasis from neuroendocrine carcinoma of the cervix: illustrative case
por: Patterson, John D., et al.
Publicado: (2023)

The development of a tumor‐associated autoantibodies panel to predict clinical outcomes for immune checkpoint inhibitor‐based treatment in patients with advanced non‐small‐cell lung cancer
por: Zhao, Jing, et al.
Publicado: (2023)

The significance of leptomeningeal collaterals in moyamoya disease
por: Yu, Jin, et al.
Publicado: (2020)

Primary leptomeningeal plasmablastic lymphoma
por: Mathews, Marlon S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_58h78daohv6joq24qgnkj9ob2s